Ownership history in RENAISSANCE TECHNOLOGIES LLC · 37 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in XENON PHARMACEUTICALS INC (XENE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 5,200 | -3,400 | -39.5% | 0.00% | $209K | $40.15 |
| 2025 Q2 | REDUCED | 8,600 | -146,100 | -94.4% | 0.00% | $269K | $31.30 |
| 2025 Q1 | ADDED | 154,700 | +141,000 | +1029.2% | 0.01% | $5.2M | $33.55 |
| 2024 Q4 | REDUCED | 13,700 | -30,300 | -68.9% | 0.00% | $537K | $39.20 |
| 2024 Q3 | REDUCED | 44,000 | -48,900 | -52.6% | 0.00% | $1.7M | $39.37 |
| 2024 Q2 | ADDED | 92,900 | +36,500 | +64.7% | 0.01% | $3.6M | $38.99 |
| 2024 Q1 | ADDED | 56,400 | +23,800 | +73.0% | 0.00% | $2.4M | $43.05 |
| 2023 Q4 | ADDED | 32,600 | +10,700 | +48.9% | 0.00% | $1.5M | $46.06 |
| 2023 Q3 | REDUCED | 21,900 | -128,877 | -85.5% | 0.00% | $748K | $34.16 |
| 2022 Q1 | REDUCED | 150,777 | -230,100 | -60.4% | 0.01% | $4.6M | $30.57 |
As of 2025 Q4 — sorted by position size